Priscilla K. Brastianos, MD, explains the differences between low-grade meningiomas and aggressive high-grade tumors.
Priscilla K. Brastianos, MD
Advertisement
Articles by Priscilla K. Brastianos, MD
Advertisement
Latest Updated Articles
- Dr. Brastianos on Recent Data in High-Grade Meningiomas
Published: April 4th 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5

